Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Accenture
Colorcon
Express Scripts
McKinsey
Dow
Queensland Health
Cerilliant
Johnson and Johnson

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205171

« Back to Dashboard
NDA 205171 describes ALMOTRIPTAN MALATE, which is a drug marketed by Ajanta Pharma Ltd, Teva Pharms Usa, and Mylan Pharms Inc, and is included in three NDAs. It is available from three suppliers. Additional details are available on the ALMOTRIPTAN MALATE profile page.

The generic ingredient in ALMOTRIPTAN MALATE is almotriptan malate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the almotriptan malate profile page.

Summary for NDA: 205171

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimigraine Agents

Pharmacology for NDA: 205171

Suppliers and Packaging for NDA: 205171

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL 205171 ANDA Mylan Pharmaceuticals Inc. 0378-5245 0378-5245-85 1 BLISTER PACK in 1 CARTON (0378-5245-85) > 6 TABLET, FILM COATED in 1 BLISTER PACK (0378-5245-32)
ALMOTRIPTAN MALATE
almotriptan malate
TABLET;ORAL 205171 ANDA Mylan Pharmaceuticals Inc. 0378-5246 0378-5246-85 2 BLISTER PACK in 1 CARTON (0378-5246-85) > 6 TABLET, FILM COATED in 1 BLISTER PACK (0378-5246-32)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 6.25MG BASE
Approval Date:Nov 9, 2015TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 12.5MG BASE
Approval Date:Nov 9, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Moodys
QuintilesIMS
Harvard Business School
Deloitte
Express Scripts
Daiichi Sankyo
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot